CN113974166A - Instant powder for regulating blood sugar balance - Google Patents
Instant powder for regulating blood sugar balance Download PDFInfo
- Publication number
- CN113974166A CN113974166A CN202111298185.5A CN202111298185A CN113974166A CN 113974166 A CN113974166 A CN 113974166A CN 202111298185 A CN202111298185 A CN 202111298185A CN 113974166 A CN113974166 A CN 113974166A
- Authority
- CN
- China
- Prior art keywords
- blood sugar
- powder
- parts
- instant powder
- balance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000000346 sugar Nutrition 0.000 title claims abstract description 60
- 210000004369 blood Anatomy 0.000 title claims abstract description 51
- 239000008280 blood Substances 0.000 title claims abstract description 51
- 239000000843 powder Substances 0.000 title claims abstract description 43
- 230000001105 regulatory effect Effects 0.000 title claims description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 16
- 235000009566 rice Nutrition 0.000 claims abstract description 16
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 11
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920002752 Konjac Polymers 0.000 claims abstract description 6
- 235000010485 konjac Nutrition 0.000 claims abstract description 6
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 5
- 238000013329 compounding Methods 0.000 claims abstract description 4
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 4
- 240000007594 Oryza sativa Species 0.000 claims abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 5
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 4
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 239000000252 konjac Substances 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 3
- 241000209140 Triticum Species 0.000 abstract description 10
- 235000021307 Triticum Nutrition 0.000 abstract description 10
- 235000013339 cereals Nutrition 0.000 abstract description 10
- 230000003750 conditioning effect Effects 0.000 abstract description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract description 9
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 108010050181 aleurone Proteins 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 239000000845 maltitol Substances 0.000 abstract description 4
- 235000010449 maltitol Nutrition 0.000 abstract description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 abstract description 4
- 229940035436 maltitol Drugs 0.000 abstract description 4
- 239000000600 sorbitol Substances 0.000 abstract description 4
- 241000209763 Avena sativa Species 0.000 abstract description 3
- 240000006162 Chenopodium quinoa Species 0.000 abstract description 3
- 240000008620 Fagopyrum esculentum Species 0.000 abstract description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract description 3
- 208000013016 Hypoglycemia Diseases 0.000 abstract description 2
- 235000003642 hunger Nutrition 0.000 abstract description 2
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 2
- 150000008163 sugars Chemical class 0.000 abstract 1
- 241000209094 Oryza Species 0.000 description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 229930006000 Sucrose Natural products 0.000 description 13
- 229960004793 sucrose Drugs 0.000 description 13
- 239000005720 sucrose Substances 0.000 description 10
- 210000002540 macrophage Anatomy 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 229960002920 sorbitol Drugs 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 238000001994 activation Methods 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/362—Leguminous plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides instant powder for conditioning blood sugar balance, which is prepared from the following components in parts by weight: 45 parts of isomaltulose; 39 parts of coarse grain compound powder (oat, buckwheat, quinoa and the like); 5 parts of rice germ; 5 parts of wheat aleurone layer; 3 parts of konjak powder; 1 part of maltitol; 1 part of sorbitol; 0.5 part of white kidney bean extract; 0.3 part of L-arabinose; inulin-0.1 part; 0.1 part of chitosan oligosaccharide. The functional brewing powder for conditioning blood sugar balance disclosed by the invention is prepared by compounding isomaltulose, coarse grain compound powder, rice germ, wheat aleurone layer and various sugars, so that the functional brewing powder not only can help a diabetic to effectively control blood sugar, but also has obvious effects on the aspects of preventing hypoglycemia, delaying hunger, preventing and treating cardiovascular and cerebrovascular complications, preventing diabetes and managing weight.
Description
Technical Field
The invention relates to functional food, in particular to instant powder for regulating blood sugar balance.
Background
Diabetes is a common disease, is one of the third chronic diseases which seriously endanger human health after tumor and cardiovascular and cerebrovascular diseases. Its effects include long-term damage, dysfunction and failure of the respective organ. Often, the symptoms of diabetes are not as severe; however, chronic hyperglycemia causes lesions in various tissues and organs throughout the body, resulting in acute and chronic complications. Such as dehydration, electrolyte disorder, nutritional deficiency, resistance decline, renal function impairment, neuropathy, fundus oculi pathological changes, cardiovascular and cerebrovascular diseases, diabetes, etc.
With the increasing standard of living, obesity and overweight have become epidemic diseases in adults and children. Excessive energy caused by excessive consumption of refined carbohydrates is an important reason for obesity, because excessive carbohydrate intake can be converted into fat to be deposited in the body, blood sugar can also be increased, the load of pancreatic islets can be increased, the risk of type 2 diabetes mellitus can be greatly increased due to long-term accumulation, and the goal of reducing energy absorption by reducing the absorption of carbohydrates in the intestinal tract is a hot point of research. The use of sucrose has been well known, and people, especially children, have hard to shake the special taste dependence of sucrose sweetness. How to not only keep the taste of the sucrose which people learn from, but also benefit from the new health concepts of low sugar, nutrition and the like of functional sugar alcohol is also a problem which confuses the food industry.
Therefore, the development of safe and effective functional food for regulating blood sugar balance has great significance for diabetes patients.
Disclosure of Invention
The invention aims to provide instant powder for conditioning blood sugar balance, which can balance dietary nutrition intake, and achieve the functions of regulating glycometabolism and conditioning blood sugar balance.
In order to achieve the purpose, the invention adopts the technical scheme that: the instant powder for regulating blood sugar balance is prepared from the following components in parts by weight:
further, the instant powder for regulating blood sugar balance comprises 45 parts of isomaltulose. Isomaltulose is functional edible sugar emerging internationally in recent years, the unique physicochemical property, physiological function and use safety of isomaltulose are fully verified by experiments, the highest grade of food safety "GRAS (generally recognized safety)" is given by the FDA in the United states, isomaltulose is not digested by saliva, gastric acid and pancreatic juice until the isomaltulose is hydrolyzed into glucose and fructose in small intestine, so that the slow and lasting effect process after use can be ensured, and the postprandial blood sugar is maintained to be stable for 4-5 hours, not high or low, and is more suitable for the requirement of blood sugar balance of diabetics.
Furthermore, the instant powder for regulating blood sugar balance comprises 5 parts of wheat aleurone layer. The wheat aleurone layer is also called as the endosperm and is the innermost cell of the wheat grain cortex and is positioned between the wheat grain seed coat and the endosperm. The aleurone layer only accounts for 7-9% of the total weight of the wheat grains, but the content of the nutrient components accounts for 60-70% of the total nutrient of the wheat. The physiological active ingredients (such as dietary fiber, mineral substances, beneficial lipids, vitamins, phenolic acids, lignans and the like) with high nutritional value in the wheat are mainly concentrated in the aleurone layer.
Further, the instant powder for regulating blood sugar balance comprises 5 parts of rice germ. The rice germ is the essence of rice, is the embryo of the rice, is a vital substance, is the meristem of the rice, is rich in nutrition required by vital movement, is rich in various nutrient substances required by human body, and is regarded as 'soft gold in plants'. The rice germ contains more than 90% of essential elements of human bodies in rice, is called as 'natural nutrition treasury', wherein the content of protein and lipid is more than 20%, the amino acid composition in the protein is relatively balanced, more than 80% of the lipid is unsaturated fatty acid, the mass fraction of the essential fatty acid reaches 47%, and the rice germ also contains more than 70 antioxidant components, contains rich trace elements and mineral substances and does not contain cholesterol. The rice germ is rich in vitamin E with high physiological activity, gamma-aminobutyric acid, glutathione, squalene, multiple vitamin B, linoleic acid, rice germ protein, inositol hexaphosphate, gamma-oryzanol, gamma-ferulic acid, N-dehydroceramide, dietary fiber, hemicellulose and the like, and the nutritive value of the rice germ is 20 times of that of the rice endosperm part.
Furthermore, the instant powder for regulating blood sugar balance comprises 3 parts of konjac flour. The konjak contains rich soluble dietary fiber, has low calorie, higher protein content than potatoes and sweet potatoes, rich trace elements, vitamin A, vitamin B and the like, particularly rich glucomannan, and has the effects of losing weight, reducing blood pressure, reducing blood sugar, expelling toxin, relaxing bowels, preventing cancer, supplementing calcium and the like. The konjac flour in the formula has the main function that glucomannan forms a gel substance after meeting water in the stomach environment, so that sufficient satiety is provided.
Further, the instant powder for regulating blood sugar balance comprises 1 part of maltitol. The sweetness of the maltitol is 85 to 95 percent of that of the cane sugar. Has the characteristics of heat resistance, acid resistance, moisture retention, non-fermentation property and the like, and basically does not cause Maillard reaction. It is not digested and absorbed in vivo, has calorific value of 5% of sucrose, and does not increase blood sugar and cholesterol.
Furthermore, the instant powder for conditioning blood sugar balance comprises 1 part of sorbitol, and preferably D-sorbitol solution. The sorbitol has sweet performance, and the D-sorbitol has cool sweet taste, and the sweetness of the D-sorbitol is about 50% -70% of that of the cane sugar. 1g D-sorbitol produced 16.7kJ of heat in the human body, and after eating, it was not converted into glucose in the blood and was not affected by insulin. In addition, the D-sorbitol has good moisture retention performance in the formula, so that the reconstituted powder keeps certain moisture, the drying is prevented, the precipitation of crystals of sugar, salt and the like can be prevented, the balance of sweetness intensity is kept, and the fragrance of the reconstituted powder is kept.
Furthermore, the instant powder for regulating blood sugar balance comprises 0.5 part of white kidney bean extract. The alpha-amylase inhibitor in the white kidney bean can thoroughly block a channel of interaction between a substrate and an active site of the alpha-amylase, so that the activity of the alpha-amylase in a human digestive system is reduced, and starch cannot be completely decomposed into micromolecular monosaccharide to be absorbed by a human body.
Furthermore, the instant powder for regulating blood sugar balance comprises 0.3 part of L-arabinose. L-arabinose can selectively affect sucrase in the small intestine, thereby inhibiting sucrose absorption. Experiments prove that the addition of 2% of arabinose into sucrose can inhibit the absorption of 40% of sucrose, and the blood sugar level is slightly increased by about 50%. Arabinose can block and inhibit the absorption of sucrose and glucose, and reduce postprandial blood sugar, so that the blood sugar is stable.
Furthermore, the instant powder for conditioning blood sugar balance comprises 0.1 part of chitosan oligosaccharide. The main role of chitosan oligosaccharide in the present invention is to enhance the immunity of diabetic patients, which has been confirmed by many scholars: the chitosan oligosaccharide stimulates the organism, promotes the increase of the cell number of peritoneal exudate, activates macrophage, thereby increasing the generation of active oxygen, and then has the effect of an oxidizing sterilization mechanism; the direct activation of the chitosan oligosaccharide to the macrophage increases the killing activity of the macrophage; the chitosan oligosaccharide activates T lymphocytes to show killing activity, and the sensitized T cells induce delayed hypersensitivity; chitosan oligosaccharide activates T lymphocytes, thereby promoting the release of Macrophage Activating Factor (MAF), which in turn activates macrophages. During the activation process, the macrophage is directly activated by the chitosan oligosaccharide, and the sensitivity of the macrophage to MAF can be improved, so that the macrophage is further activated. It is therefore believed that the killing activity of chitosan oligosaccharide occurs primarily as a result of the enhanced interaction of activated T lymphocytes with macrophages.
Furthermore, the instant powder for regulating blood sugar balance comprises 0.1 part of inulin. Inulin, a carbohydrate which does not cause an increase in urine glucose, is not hydrolyzed to monosaccharides in the upper intestinal tract, and thus does not increase blood glucose levels and insulin content. Research shows that short-chain fatty acid generated by fermentation of fructo-oligosaccharide in inulin in colon can help human body to reduce fasting blood glucose value.
The instant powder for regulating blood sugar balance can be directly eaten after being mixed with boiled water, and can also be used as raw material powder of biscuits and bread and the like.
The invention also discloses a brewing instant powder for conditioning blood sugar balance, which is prepared by the following steps: firstly, preparing coarse grain compound powder, mixing coarse grains such as oat, buckwheat and quinoa according to a proportion, baking at 200 ℃ for 20 minutes for curing, cooling, and grinding to 60 meshes; secondly, the sugar is prepared according to the formula proportion of the slow-release sugar, and is mixed evenly by 3D mixing; and thirdly, entering an automatic packaging link.
Compared with the prior art, the instant powder for regulating blood sugar balance has the following advantages:
1) in the core functional slow-release sugar formula adopted by the invention, the compounding of various functional food raw materials is adopted, and the most main component is isomaltulose, so that the effect of slowly absorbing and controlling blood sugar balance can be directly generated; the white kidney bean extract in the compound components inhibits the starch absorption process in the coarse grain powder which is necessary to be used in the preparation of the instant powder and inhibits the starch digestion and absorption process in other foods (such as thickening and the like), thereby ensuring that the starch in the foods does not generate postprandial hyperglycemia; the L-arabinose in the compound ingredients inhibits the digestion and absorption process of sucrose in other foods, thereby ensuring that the sucrose in the foods does not generate postprandial hyperglycemia.
2) The formula can improve the brain function, because the slow-release sugar formula can ensure the stable blood sugar after 4-5 hours, the problem of insufficient brain supply caused by the reduction of the blood sugar is avoided, and the mental concentration can be improved by ensuring the blood sugar supply of the brain, so that the formula is particularly useful for people who need to concentrate for a long time, such as schoolchildren, students for examinations, long-term brain thinking and the like.
3) Isomaltulose, maltitol and sorbitol, which provide sweetness in the core formulation, are not available to the oral cavity causing tooth decay microorganisms, and certainly do not produce insoluble polydextrose, so dental plaque is not formed, causing tooth decay and periodontal disease problems. In addition, the formula not only can not cause decayed teeth, but also has the effect of inhibiting decayed teeth caused by cane sugar.
4) The slow-release sugar formula can also stimulate the growth and reproduction of beneficial flora in intestinal tract and optimize the digestive system of human body.
5) The formula contains five natural polysaccharides, changes the physical state of water into gel, and provides sufficient satiety.
6) The formula contains rice germ and wheat aleurone layer which provide various nutrient substances such as calcium, iron, zinc, selenium and the like.
7) The brewing powder has the advantages of easily available raw materials, low cost and simple and easy preparation method, and the prepared brewing powder not only can help diabetics to effectively control blood sugar, but also has obvious effects on preventing hypoglycemia, delaying hunger, preventing and treating cardiovascular and cerebrovascular complications, preventing diabetes, resisting cancer, resisting rheumatoid diseases and senile dementia.
In conclusion, the brewing powder disclosed by the patent adopts a sustained-release sugar formula with a sustained-release effect, and after the sugar is taken, the blood sugar is stable and has no peak value, so that the sugar balance is regulated and controlled, and the trouble of overhigh blood sugar after meal is solved for the diabetics.
The functional brewing powder for conditioning the blood sugar balance disclosed by the patent is found to have an obvious blood sugar reducing effect on a normal mouse and two diabetes models, and meanwhile, an oral toxicity test, a two-item mutation test (a mouse bone marrow polypophilic erythrocyte micronucleus test and a sperm malformation test) and a safety evaluation test of a 30-day feeding test are carried out on the functional food for conditioning the blood sugar balance provided by the patent, and the tests show that the tested sample belongs to a non-toxic grade according to the evaluation of an acute toxicity grading standard.
Detailed Description
The invention is further illustrated by the following examples:
example 1
The embodiment discloses instant powder for conditioning blood sugar balance, which is prepared from the following components in parts by weight:
the instant powder for regulating blood sugar balance is prepared by the following steps: firstly, preparing coarse grain compound powder, mixing coarse grains such as oat, buckwheat and quinoa according to a proportion, baking at 200 ℃ for 20 minutes for curing, cooling, and grinding to 60 meshes; secondly, the sugar is prepared according to the formula proportion of the slow-release sugar, and is mixed evenly by 3D mixing; and thirdly, entering an automatic packaging link.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Claims (5)
2. the reconstitutable instant powder for regulating blood glucose balance according to claim 1, comprising isomaltulose, L-arabinose, white kidney bean extract in a compounding ratio of 45:0.3: 0.5.
3. The reconstituted instant powder for regulating blood sugar balance according to claim 1, wherein the mixing ratio of isomaltulose to konjac flour is 45: 3.
4. The instant powder for regulating blood sugar balance as claimed in claim 1, wherein the compounding ratio of the konjac powder, the inulin and the chitosan oligosaccharide is 3:0.1: 0.1.
5. The reconstituted instant powder for regulating blood glucose balance as claimed in claim 1, wherein the rice germ is separated from bran.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111298185.5A CN113974166A (en) | 2021-11-04 | 2021-11-04 | Instant powder for regulating blood sugar balance |
PCT/CN2021/128847 WO2023077394A1 (en) | 2021-11-04 | 2021-11-05 | Soluble ready-to-eat powder for regulating blood glucose balance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111298185.5A CN113974166A (en) | 2021-11-04 | 2021-11-04 | Instant powder for regulating blood sugar balance |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113974166A true CN113974166A (en) | 2022-01-28 |
Family
ID=79746360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111298185.5A Pending CN113974166A (en) | 2021-11-04 | 2021-11-04 | Instant powder for regulating blood sugar balance |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113974166A (en) |
WO (1) | WO2023077394A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103932177A (en) * | 2014-04-02 | 2014-07-23 | 上海交通大学 | Wheat aleuron brewed food applicable to patients with metabolic syndrome and preparation method thereof |
CN105211853A (en) * | 2015-09-21 | 2016-01-06 | 河南科技大学 | Blood sugar reducing health composition, electuary and preparation method thereof |
CN108294231A (en) * | 2017-12-19 | 2018-07-20 | 丽睿客信息科技(北京)有限公司 | It is suitble to the nutritional staple food of patients with diabetes mellitus |
CN109247482A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | Diabetic's solid beverage and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1410721E (en) * | 2002-10-17 | 2006-09-29 | Suedzucker Ag | METHOD FOR PREPARING AN ENTERIC FOOD CONTAINING ISOMALTULOSE |
CN104171842A (en) * | 2014-07-15 | 2014-12-03 | 嘉兴市禾新科技创业投资有限公司 | Wheat aleurone layer flour |
CN104366213A (en) * | 2014-11-13 | 2015-02-25 | 宁夏万齐农业发展集团有限公司 | Wheat germ and celery compound rice and production method thereof |
CN105053866B (en) * | 2015-08-10 | 2018-09-25 | 上海量健企业管理咨询服务有限公司 | A kind of compound germ flour and preparation method thereof to relax bowel |
CN108112996B (en) * | 2017-12-12 | 2021-02-05 | 法尔玛国际健康管理有限公司 | Nutritional composition for controlling hyperglycemia and improving immunity of type 2 diabetes mellitus people |
CN108174900A (en) * | 2018-01-11 | 2018-06-19 | 思朗食品(淮北)有限公司 | The hypoglycemia generation value that a kind of suitable diabetic population is eaten(GI)Biscuit |
CN111034999A (en) * | 2019-12-31 | 2020-04-21 | 北京康比特体育科技股份有限公司 | Composition with sugar-resisting and weight-losing functions |
-
2021
- 2021-11-04 CN CN202111298185.5A patent/CN113974166A/en active Pending
- 2021-11-05 WO PCT/CN2021/128847 patent/WO2023077394A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103932177A (en) * | 2014-04-02 | 2014-07-23 | 上海交通大学 | Wheat aleuron brewed food applicable to patients with metabolic syndrome and preparation method thereof |
CN105211853A (en) * | 2015-09-21 | 2016-01-06 | 河南科技大学 | Blood sugar reducing health composition, electuary and preparation method thereof |
CN109247482A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | Diabetic's solid beverage and preparation method thereof |
CN108294231A (en) * | 2017-12-19 | 2018-07-20 | 丽睿客信息科技(北京)有限公司 | It is suitble to the nutritional staple food of patients with diabetes mellitus |
Non-Patent Citations (1)
Title |
---|
冯延民: "《壳寡糖与人类健康》", 31 March 2008, 吉林大学出版社 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023077394A1 (en) | 2023-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109511851A (en) | A kind of solid beverage and preparation method thereof before the meal reducing food glycemic index | |
CN102273585B (en) | Health-care porridge with effect of relaxing bowel and preparation method thereof | |
CN104872558A (en) | Low-GI (glycemic index) brewing porridge and preparing method thereof | |
CN111011862B (en) | Edible composition, low glycemic index nutrition powder and preparation method thereof | |
CN111066847A (en) | Low GI (glycemic index) moon cake suitable for diabetics and preparation method thereof | |
CN101912090B (en) | Highland barley health care porridge assisting for reducing blood fat and preparation method thereof | |
CN106880058B (en) | Sugar-free syrup and preparation method thereof | |
CN106690331A (en) | Kelp dietary fiber granules and preparation method thereof | |
CN106820069A (en) | A kind of natural built-up sweetener with regulating intestinal canal function and preparation method thereof | |
CN111406800A (en) | Low-GI yogurt suitable for diabetics and preparation method thereof | |
CN112369606A (en) | Low-carbon ketogenic food and preparation method thereof | |
CN103975991A (en) | Healthcare mulberry anthocyanidin biscuit | |
CN114651982A (en) | Composition capable of delaying postprandial blood sugar, preparation method and application thereof | |
CN111213690A (en) | Formula and preparation method of low-GI chickpea starch bread | |
CN108113002B (en) | Meal accompanying powder for reducing blood sugar response and fat absorption and preparation method thereof | |
CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
EP3416502B1 (en) | Glycemic reducing composition | |
CN107410631A (en) | A kind of multi-functional glycoconjugate and preparation method and application | |
CN107259363A (en) | Diabetes patient's five cereals meal replacement powder | |
CN111165709A (en) | Solid beverage with blood sugar control function and preparation method thereof | |
CN108095054B (en) | A plant capsule for reducing digestion and absorption of sugar in diet, and its preparation method | |
CN113974166A (en) | Instant powder for regulating blood sugar balance | |
CN108902607A (en) | A kind of multifunctional nanocrystalline dietary fiber beverage and its preparation process | |
CN113973867A (en) | Functional biscuit for conditioning blood sugar balance | |
CN114176180A (en) | Functional beverage for conditioning blood sugar balance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220128 |